Conclusions: EFCAB7 might be a core contributor to HCC cells’ malignant transformation after RFA and could be a potential novel target to provide a therapeutic strategy for the prevention of recurrence after RFA in HCC. This evidence concerns the gene EFCAB7 and hepatocellular carcinoma.